ASV Insights presents the Top 10 Deals of 2023 where we look at how recent major successes reflect the latest trends in women’s health and sexual health. This week we assess the acquisition of Binx Health, an at-home STI testing company and consider similar pioneers in the sexual health space. In December of this year, consumer testing and molecular diagnostics company, Imaware, acquired Binx Health’s at-home testing business. Binx Health had previously raised nearly $200 million from EQT Life Sciences, RMI Partners, Novartis, OrbiMed and J&J. Imaware is a privately held company offering p ..read more

ASV Insights presents the Top 10 Deals of 2023 where we will look at how recent major successes reflect the latest trends in women’s health and sexual health. This week we discuss what the acquisition of Intrarosa means for the industry and consider similar pioneers in the women’s health space. Earlier this year Cosette Pharmaceuticals acquired Intrarosa, the only FDA-approved, locally administered, daily, non-estrogen product for the treatment of dyspareunia, a common symptom of vaginal atrophy due to menopause. The transaction includes the transfer of 108 issued and pending global patents ..read more

ASV Insights presents the Top 10 Deals of 2023 where we will look at how recent major successes reflect the latest trends in women’s health and sexual health. This week we discuss what the acquisition of Intrarosa means for the industry and consider similar pioneers in the women’s health space. Earlier this year Cosette Pharmaceuticals acquired Intrarosa, the only FDA-approved, locally administered, daily, non-estrogen product for the treatment of dyspareunia, a common symptom of vaginal atrophy due to menopause. The transaction includes the transfer of 108 issued and pending global patents ..read more

ASV Insights presents the Top 10 Deals of 2023 where we will look at how recent major successes reflect the latest trends in women’s health and sexual health. This week we acknowledge Evernow’s fundraising success and highlight the positive impact they are making in the field of women’s health. Evernow; a telehealth company, dedicated to transforming care for women in perimenopause and menopause has secured $28.5 million in Series A funding. The round was led by NEA with contributions from 8VC, Refactor Capital, Coelius Capital and notable figures like Gwyneth Paltrow, Carla Harris, Drew B ..read more

ASV Insights presents the Top 10 Deals of 2023 where we will look at how recent major successes reflect the latest trends in women’s health and sexual health. This week we discuss what the acquisition of XinThera means for the industry and consider similar pioneers in the women’s health space. In May of this year XinThera, a breast cancer therapeutics startup, was acquired by Gilead, a leading biopharma company in the US. Gilead did not disclose the price of the deal, however; XinThera previously raised $50 million in an August 2021 series B, bringing its total raise, at that time, to $80 mil ..read more

ASV Insights presents the Top 10 Deals of 2023 where we will look at how recent major successes reflect the latest trends in women’s health and sexual wellbeing. This week we reflect on the remarkable trajectory of Kindbody’s growth, applauding their substantial fundraising achievements, underscoring the positivity it brings to the women’s health sector. Kindbody, a prominent tech-driven fertility and family building benefits provider, has secured $100 Million in funding from Perceptive Advisors, a renowned life sciences investment firm. This takes Kindbody’s total funding to over $290 Mill ..read more

ASV Insights presents the Top 10 Deals of 2023 where we will look at how recent major successes reflect the latest trends in women’s health and sexual wellbeing. This week we look at the pregnancy and maternal health landscape following the intended merger of Nuvo Group and LAMF Global Ventures. Founded in 2014, Israeli-based pregnancy care company, Nuvo Group, entered into an LOI to merge with LAMF Global Ventures, a Special Purpose Acquisition Company (SPAC). Nuvo is valued at $269 million with potential to grow to $300 million should Nuvo hit a specified commercial target. The LOI was si ..read more

ASV Insights presents the Top 10 Deals of 2023 where we will look at how recent major successes reflect the latest trends in women’s health and sexual wellbeing. This week we discuss what the acquisition of Thorne HealthTech means for the industry and consider similar pioneers in the women’s health space. Spurred on by the growing wellness economy, US- headquartered private equity firm, L. Catterton acquired South Carolina-based personalized health and wellness company, Thorne HealthTech Inc., in a $680M deal. The success of similar hormone testing and supplement companies like Everlywell, w ..read more

Amboy Street Ventures is thrilled to participate in the Series A round of Evvy, a company committed to restoring equity in healthcare by leveraging overlooked female biomarkers, starting with the vaginal microbiome. Amboy Street also participated in Evvy’s Seed round. In 2021, Evvy launched the at-home vaginal microbiome test leveraging metagenomic sequencing to elucidate what’s up down there. Insights from their test led to the expansion of Evvy’s innovative vaginal health platform, combining state-of-the-art testing, precision care, and proactive tracking to give women and people with vagi ..read more

The Amboy Street Ventures’ Industry Insights series features a collection of pieces authored by experts in the women’s health and sexual health space. This week, Ute M. Arndt, reveals what CPG conglomerates find valuable when considering a start-up for acquisition. Introduction to the author – Ute M. Arndt Ute is an acclaimed Brand and Innovation authority and an expert in CPG and Feminine & Intimate Care. She brings a wealth of commercial experience having worked for some of the world’s leading players across diverse industries including; Essity, Intel and Amazon. Ut ..read more